60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Meta-regression of predictors of placebo response
Stefan Leucht(TUM Klinikum), John M. Davis(University of Illinois Chicago), Maximilian Huhn(Klinikum rechts der Isar), Myrto Samara(Klinikum rechts der Isar), John Geddes(University of Oxford), Bartosz Helfer(University of Illinois Chicago), Claudia Leucht(University of Illinois Chicago), Dimitris Mavridis(Délégation Paris 5), Georgia Salanti(University of Bern), Anna Chaimani(Inserm), Andrea Cipriani(Oxford Health NHS Foundation Trust)
Cited by 39
Related Papers
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
|Annals of Internal Medicine|2015|8.2k
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
|Journal of Clinical Epidemiology|2010|3.8k
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis
|The Lancet|2018|3.5k